PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives

Advanced, recurrent and metastatic endometrial cancer (EC) has a dismal prognosis due to poor response rates to conventional treatments. In the era of precision medicine, the improved understanding of cancer genetics and molecular biology has led to the development of targeted therapies, such as pol...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Manag Res
Main Authors: Musacchio, Lucia, Caruso, Giuseppe, Pisano, Carmela, Cecere, Sabrina Chiara, Di Napoli, Marilena, Attademo, Laura, Tambaro, Rosa, Russo, Daniela, Califano, Daniela, Palaia, Innocenza, Muzii, Ludovico, Benedetti Panici, Pierluigi, Pignata, Sandro
Formato: Artigo
Idioma:Inglês
Publicado: Dove 2020
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7383016/
https://ncbi.nlm.nih.gov/pubmed/32801862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S221001
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares